Literature DB >> 10764832

MUC1: the polymorphic appearance of a human mucin.

F G Hanisch1, S Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10764832     DOI： 10.1093/glycob/10.5.439

Source DB:  PubMed          Journal:  Glycobiology        ISSN： 0959-6658            Impact factor:   4.313


× No keyword cloud information.
  59 in total

1.  Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.

Authors:  Carol L Kinlough; Paul A Poland; Sandra J Gendler; Polly E Mattila; Di Mo; Ora A Weisz; Rebecca P Hughey
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

Review 2.  Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision.

Authors:  María V Croce; Marina Isla-Larrain; Martín E Rabassa; Sandra Demichelis; Andrea G Colussi; Marina Crespo; Ezequiel Lacunza; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

Review 3.  Trousseau's syndrome: multiple definitions and multiple mechanisms.

Authors:  Ajit Varki
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

4.  O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.

Authors:  D Stepensky; E Tzehoval; E Vadai; L Eisenbach
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

5.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

6.  Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors.

Authors:  Vitaly Vasilevko; Anahit Ghochikyan; Nadya Sadzikava; Irina Petrushina; Mike Tran; Edward P Cohen; Patrick J Kesslak; David H Cribbs; Garth L Nicolson; Michael G Agadjanyan
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.

Authors:  Sampat Ingale; Margreet A Wolfert; Therese Buskas; Geert-Jan Boons
Journal:  Chembiochem       Date:  2009-02-13       Impact factor: 3.164

8.  Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes.

Authors:  David J Gill; Joanne Chia; Jamie Senewiratne; Frederic Bard
Journal:  J Cell Biol       Date:  2010-05-24       Impact factor: 10.539

9.  Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins--towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation.

Authors:  Sasha M Daskalova; Josiah E Radder; Zbigniew A Cichacz; Sam H Olsen; George Tsaprailis; Hugh Mason; Linda C Lopez
Journal:  BMC Biotechnol       Date:  2010-08-24       Impact factor: 2.563

10.  Temporal and spatial expression of Muc1 during implantation in sows.

Authors:  Qian Ren; Shu Guan; Jinluan Fu; Aiguo Wang
Journal:  Int J Mol Sci       Date:  2010-05-27       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.